PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 98107947 |
Filing Date: 07/29/2023 |
Input Field |
Entered |
TEAS Plus | YES |
---|---|
MARK INFORMATION | |
*MARK | \\TICRS\EXPORT18\IMAGEOUT 18\981\079\98107947\xml1 \ FTK0002.JPG |
*SPECIAL FORM | YES |
USPTO-GENERATED IMAGE | NO |
LITERAL ELEMENT | NUVTEYMA |
*COLOR MARK | NO |
*COLOR(S) CLAIMED (If applicable) |
|
*DESCRIPTION OF THE MARK (and Color Location, if applicable) |
The mark consists of NUVTEYMA followed by a design of overlapping spherical triangles. |
PIXEL COUNT ACCEPTABLE | YES |
PIXEL COUNT | 590 x 252 |
REGISTER | Principal |
APPLICANT INFORMATION | |
*OWNER OF MARK | Insmed Incorporated |
*MAILING ADDRESS | 700 Route 202/206 |
*CITY | Bridgewater |
*STATE (Required for U.S. applicants) |
New Jersey |
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
*ZIP/POSTAL CODE (Required for U.S. and certain international addresses) |
08807 |
*EMAIL ADDRESS | XXXX |
LEGAL ENTITY INFORMATION | |
*TYPE | CORPORATION |
* STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY OF INCORPORATION | Virginia |
GOODS AND/OR SERVICES AND BASIS INFORMATION | |
*INTERNATIONAL CLASS | 005 |
*IDENTIFICATION | Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; Pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; Pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; Pharmaceutical preparations for the treatment and prevention of rhinitis; Pharmaceutical preparations for the treatment and prevention of Behcet's disease; Pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; Pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; Pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions; Pharmaceutical preparations for the treatment and prevention of chronic rhinosinusitis; Pharmaceutical preparations for the treatment and prevention of hidradenitis suppurativa; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of metastasis |
*FILING BASIS | SECTION 1(b) |
ADDITIONAL STATEMENTS SECTION | |
*TRANSLATION (if applicable) |
|
*TRANSLITERATION (if applicable) |
|
*CLAIMED PRIOR REGISTRATION (if applicable) |
|
*CONSENT (NAME/LIKENESS) (if applicable) |
|
*CONCURRENT USE CLAIM (if applicable) |
|
ATTORNEY INFORMATION | |
NAME | Peter J. Willsey |
ATTORNEY DOCKET NUMBER | 35555/296 |
ATTORNEY BAR MEMBERSHIP NUMBER | XXX |
YEAR OF ADMISSION | XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY | XX |
FIRM NAME | Brown Rudnick LLP |
STREET | 601 Thirteenth Street NW Suite 600 |
CITY | Washington |
STATE | District of Columbia |
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY | United States |
ZIP/POSTAL CODE | 20005 |
PHONE | 202-536-1751 |
FAX | 617-289-0851 |
EMAIL ADDRESS | trademarks@brownrudnick.com |
OTHER APPOINTED ATTORNEY | Vincent J. Badolato, Daniel J. Healy, Katherine C. Dearing, Jason M. Sobel, Ian G. DiBernardo, Scott M. Smedresman, Merri C. Moken, Morgan Jones, Alvin B. Carter III and Stephanie P. Calnan |
CORRESPONDENCE INFORMATION | |
NAME | Peter J. Willsey |
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE | trademarks@brownrudnick.com |
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) | pwillsey@brownrudnick.com; doakes@brownrudnick.com |
FEE INFORMATION | |
APPLICATION FILING OPTION | TEAS Plus |
NUMBER OF CLASSES | 1 |
APPLICATION FOR REGISTRATION PER CLASS | 250 |
*TOTAL FEES DUE | 250 |
*TOTAL FEES PAID | 250 |
SIGNATURE INFORMATION | |
* SIGNATURE | /Joshua Marcus/ |
* SIGNATORY'S NAME | Joshua Marcus, Ph.D. |
* SIGNATORY'S POSITION | VP, Chief IP Counsel |
SIGNATORY'S PHONE NUMBER | 732-487-7349 |
* DATE SIGNED | 07/28/2023 |
SIGNATURE METHOD | Sent to third party for signature |
PTO- 1478 |
Approved for use through 10/31/2024. OMB 0651-0009 |
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number |
Serial Number: 98107947 |
Filing Date: 07/29/2023 |
The applicant's current Correspondence Information: |
Peter J. Willsey |
PRIMARY EMAIL FOR CORRESPONDENCE: trademarks@brownrudnick.com SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): pwillsey@brownrudnick.com; doakes@brownrudnick.com Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS). |
|
|